Invega Sustenna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials
• Forums

A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Condition:   Schizophrenia Interventions:   Combination Product: Aripiprazole Lauroxil;   Drug: Paliperidone Palmitate Sponsor:   Alkermes, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Paliperidone Palmitate 6-Month Formulation
Condition:   Schizophrenia Interventions:   Drug: PP6M 700 mg eq.;   Drug: PP6M 1000 mg eq.;   Drug: PP3M 350 mg eq.;   Drug: PP3M 525 mg eq.;   Drug: PP1M;   Other: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Condition:   Schizophrenia Interventions:   Combination Product: Aripiprazole Lauroxil;   Drug: Paliperidone Palmitate Sponsor:   Alkermes, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Paliperidone Palmitate 6-Month Formulation
Condition:   Schizophrenia Interventions:   Drug: PP6M 700 mg eq.;   Drug: PP6M 1000 mg eq.;   Drug: PP3M 350 mg eq.;   Drug: PP3M 525 mg eq.;   Drug: PP1M;   Other: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Condition:   Schizophrenia Interventions:   Combination Product: Aripiprazole Lauroxil;   Drug: Paliperidone Palmitate Sponsor:   Alkermes, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Paliperidone Palmitate 6-Month Formulation
Condition:   Schizophrenia Interventions:   Drug: PP6M 700 mg eq.;   Drug: PP6M 1000 mg eq.;   Drug: PP3M 350 mg eq.;   Drug: PP3M 525 mg eq.;   Drug: PP1M;   Other: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Condition:   Schizophrenia Interventions:   Combination Product: Aripiprazole Lauroxil;   Drug: Paliperidone Palmitate Sponsor:   Alkermes, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Paliperidone Palmitate 6-Month Formulation
Condition:   Schizophrenia Interventions:   Drug: PP6M 700 mg eq.;   Drug: PP6M 1000 mg eq.;   Drug: PP3M 350 mg eq.;   Drug: PP3M 525 mg eq.;   Drug: PP1M;   Other: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Condition:   Schizophrenia Interventions:   Combination Product: Aripiprazole Lauroxil;   Drug: Paliperidone Palmitate Sponsor:   Alkermes, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Paliperidone Palmitate 6-Month Formulation
Condition:   Schizophrenia Interventions:   Drug: PP6M 700 mg eq.;   Drug: PP6M 1000 mg eq.;   Drug: PP3M 350 mg eq.;   Drug: PP3M 525 mg eq.;   Drug: PP1M;   Other: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Condition:   Schizophrenia Interventions:   Combination Product: Aripiprazole Lauroxil;   Drug: Paliperidone Palmitate Sponsor:   Alkermes, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials

A Study of Paliperidone Palmitate 6-Month Formulation
Condition:   Schizophrenia Interventions:   Drug: PP6M 700 mg eq.;   Drug: PP6M 1000 mg eq.;   Drug: PP3M 350 mg eq.;   Drug: PP3M 525 mg eq.;   Drug: PP1M;   Other: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials